Hudson Bay Capital Management »

Fate Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $68k 25k 2.70
2024-03-31 $3.4M 460k 7.34
2022-12-31 $522k 52k 10.09

More positions owned by Hudson Bay Capital Management

Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Taiwan Semiconductor Manufac Sponsored Ads Call Option (TSM)
NVIDIA Corporation Call Option (NVDA)
Advanced Micro Devices Call Option (AMD)
Palantir Technologies Cl A Put Option (PLTR)
Sandisk Corp Put Option (SNDK)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Berkshire Hathaway Inc Del Cl B New Call Option (BRK.B)
Microsoft Corporation Call Option (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Netflix Call Option (NFLX)
Apple Call Option (AAPL)
Echostar Corp Note 3.875%11/3 (Principal)

View all positions for Hudson Bay Capital Management

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Acadian Asset Management
AQR Capital Management
Two Sigma Investments
Johnson & Johnson
Renaissance Technologies
Millennium Management
State Street Corporation
Goldman Sachs Group
Geode Capital Management
Jane Street
Citadel Advisors

View all funds holding Fate Therapeutics